COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course

被引:124
|
作者
Landstra, Cyril P. [1 ]
de Koning, Eelco J. P. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands
来源
关键词
diabetes; COVID-19; SARS-CoV-2; coronavirus; severity; mortality; comorbidities; treatment; INSULIN-SECRETION; SYSTEM INHIBITORS; OXIDATIVE STRESS; TYPE-2; MORTALITY; HYPERGLYCEMIA; CORONAVIRUS; OUTCOMES; PREVALENCE; COMORBIDITIES;
D O I
10.3389/fendo.2021.649525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most important risk factors for a severe course of COVID-19. Several factors that are often present in diabetes mellitus are likely to contribute to this risk, such as older age, a proinflammatory and hypercoagulable state, hyperglycemia and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease and obesity). On the other hand, a severe COVID-19 infection, and its treatment with steroids, can have a specific negative impact on diabetes itself, leading to worsening of hyperglycemia through increased insulin resistance and reduced beta-cell secretory function. Worsening hyperglycemia can, in turn, adversely affect the course of COVID-19. Although more knowledge gradually surfaces as the pandemic progresses, challenges in understanding the interrelationship between COVID-19 and diabetes remain.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Diabetes severity and the risks of COVID-19 infection and severe COVID-19 outcomes
    Dublin, Sascha
    Floyd, James
    Walker, Rod
    Kuntz, Jennifer
    Shortreed, Susan
    Fortmann, Stephen
    Bayliss, Elizabeth
    Harrington, Laura
    Fuller, Sharon
    Albertson-Junkans, Ladia
    Powers, John
    Lee, Mi
    Temposky, Lisa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 40 - 40
  • [2] Dissecting the Interrelationship between COVID-19 and Diabetes Mellitus
    Roham, Pratiksha H.
    Kamath, Jayesh J.
    Sharma, Shilpy
    ADVANCED BIOLOGY, 2023, 7 (08):
  • [3] COVID-19: Comorbidities predispose to severe Course
    Franke, Katharina
    PNEUMOLOGIE, 2020, 74 (05): : 255 - 255
  • [4] COVID-19: Comorbidities predispose to severe Course
    Franke, Katharina
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (09) : 588 - 588
  • [5] COVID-19: Comorbidities predispose to severe Course
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2020, 9 (02) : 118 - 118
  • [6] The Centrality of Obesity in the Course of Severe COVID-19
    Liu, Danfei
    Zhang, Tongyue
    Wang, Yijun
    Xia, Limin
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [7] COVID-19 digitization in maritime: understanding cyber risks
    Kristen Kuhn
    Salih Bicakci
    Siraj Ahmed Shaikh
    WMU Journal of Maritime Affairs, 2021, 20 : 193 - 214
  • [8] COVID-19 digitization in maritime: understanding cyber risks
    Kuhn, Kristen
    Bicakci, Salih
    Shaikh, Siraj Ahmed
    WMU JOURNAL OF MARITIME AFFAIRS, 2021, 20 (02) : 193 - 214
  • [9] COVID-19 and Type 2 Diabetes: Children Spared from Severe Disease Course
    Cymbaluk, Anna
    Astudillo, Marcela
    Desalvo, Daniel
    Bacha, Fida
    Mckay, Siripoom
    Redondo, Maria J.
    DIABETES, 2021, 70
  • [10] Impact of untreated diabetes and COVID-19-related diabetes on severe COVID-19
    Ushigome, Emi
    Hamaguchi, Masahide
    Sudo, Kazuki
    Kitagawa, Nobuko
    Kondo, Yuriko
    Imai, Dan
    Hattori, Tomohito
    Matsui, Takaaki
    Yamazaki, Masahiro
    Sawa, Teiji
    Fukui, Michiaki
    HELIYON, 2022, 8 (01)